Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2011 Financial Results
January 26 2012 - 9:15AM
Business Wire
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today
that its fourth quarter and full year 2011 financial results will
be released before the market opens on Tuesday, February 28, 2012
and will be available on Impax’s Web site at www.impaxlabs.com. The
Company will host a conference call and live webcast with financial
analysts at 11:00 a.m., Eastern Time.
The live webcast will be accessible through the Investor
Relations section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877)
356-3814 (in the U.S.) and (706) 758-0033 (international callers)
beginning 10 minutes prior to the scheduled start of the call.
A replay of the conference call will be available for seven days
shortly after the call. To access the replay, dial (855) 859-2056
(in the U.S.) and (404) 537-3406 (international callers). The
access conference code is 18040631.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty
pharmaceutical company applying its formulation expertise and drug
delivery technology to the development of controlled-release and
specialty generics in addition to the development of branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where
strategically appropriate, Impax has developed marketing
partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a
full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web
site at: www.impaxlabs.com.
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From May 2024 to Jun 2024
Impax Laboratories, Inc. (delisted) (NASDAQ:IPXL)
Historical Stock Chart
From Jun 2023 to Jun 2024